Preexisting Autoimmune Disease: Implications for Immune Checkpoint Inhibitor Therapy in Solid Tumors.

Kennedy, Laura C; Bhatia, Shailender; Thompson, John A; Grivas, Petros

Kennedy, Laura C; Bhatia, Shailender; Thompson, John A; Grivas, Petros.

Affiliation

Kennedy LC; Department of Medicine, Division of Oncology, University of Washington, and.
Bhatia S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Thompson JA; Department of Medicine, Division of Oncology, University of Washington, and.
Grivas P; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

J Natl Compr Canc Netw ; 17(6): 750-757, 2019 06 01.

Article in En | MEDLINE | ID: mdl-31200356

Subject(s)

Antineoplastic Agents, Immunological/adverse effects; Autoimmune Diseases/immunology; Drug-Related Side Effects and Adverse Reactions/prevention & control; Neoplasms/drug therapy; Patient Selection; Autoimmune Diseases/complications; B7-H1 Antigen/antagonists & inhibitors; B7-H1 Antigen/immunology; CTLA-4 Antigen/antagonists & inhibitors; CTLA-4 Antigen/immunology; Drug-Related Side Effects and Adverse Reactions/immunology; Humans; Neoplasms/complications; Neoplasms/immunology; Neoplasms/mortality; Programmed Cell Death 1 Receptor/antagonists & inhibitors; Programmed Cell Death 1 Receptor/immunology; Progression-Free Survival

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoimmune Diseases / Patient Selection / Drug-Related Side Effects and Adverse Reactions / Antineoplastic Agents, Immunological / Neoplasms Limits: Humans Language: En Journal: J Natl Compr Canc Netw Journal subject: NEOPLASIAS Year: 2019 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google